key: cord-0862366-uusi3nph authors: Zu, Zi Yue; Jiang, Meng Di; Xu, Peng Peng; Chen, Wen; Ni, Qian Qian; Lu, Guang Ming; Zhang, Long Jiang title: Coronavirus Disease 2019 (COVID-19): A Perspective from China date: 2020-02-21 journal: Radiology DOI: 10.1148/radiol.2020200490 sha: fd514d03eaacb50fd516cf88a71ac8b182cb1f54 doc_id: 862366 cord_uid: uusi3nph In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection occurred in Wuhan, Hubei Province, China and spread across China and beyond. On February 12, 2020, WHO officially named the disease caused by the novel coronavirus as Coronavirus Disease 2019 (COVID-19). Since most COVID-19 infected patients were diagnosed with pneumonia and characteristic CT imaging patterns, radiological examinations have become vital in early diagnosis and assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19, while highlighting the role of chest CT in prevention and disease control. A full translation of this article in Chinese is available in the supplement. - 请见䃼充资料阅读文章中文版∘ I n P r e s s , the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses finally designated it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on phylogeny, taxonomy and established practice (21) . Soon later, WHO named the disease caused by this coronavirus as Coronavirus Disease 2019 (COVID-19) (9) . On the basis of current data, it seems that COVID-19 might be initially hosted by bats, and might have been transmitted to humans via pangolin (22) or other wild animals (17, 23) sold at the Huanan seafood market but subsequent spread via human-to-human transmission. On December, 2019, the earliest symptom onset of confirmed patients appeared (24) . At first, the morbidity remained low but reached a tipping point in the middle of January 2020. During the second half of this month, a remarkable increase of infected patients in affected cities occurred outside Hubei province because of the population movement before lunar Chinese New Year (25) . Followed by an exponential growth until January 23, 2020, the outbreak spread to the other countries, attracting extensive attention around the world (Figure 1) . Evidence of clusters of infected family members and medical workers confirmed the presence of humanto-human transmission (12) by droplets, contact and fomite (26) (27) . So far, there is no definite evidence for intrauterine infection (28) . Current estimates are that COVID-19 has a median incubation period of 3 days (range 0 to 24 days), with potential asymptomatic transmission (26, 29) . At the end of January 2020, WHO confirmed more than ten thousand cases infected with COVID-19 across China (30) . On February 13, 2020, 13332 new clinically diagnosed cases were firstly reported from Hubei. Official reports included clinically diagnosed cases and laboratory-confirmed cases because chest CT findings are recommended as the major evidence for clinically confirmed cases by Diagnosis and Treatment Program of 2019 New Coronavirus Pneumonia (trial Fifth version) by National Health and Health Commission of China in 2020 (13) . As of February 19, 2020, this rose to a total of 74280 confirmed cases in China and 924 confirmed cases in 24 countries outside China, and a total of 2009 deaths globally (10) (Figure 2) . To control COVID-19, effective prevention and control measurements must include early detection, diagnosis, treatment, and quarantine to block human-to-human transmission as well as reducing secondary infections among close contacts and health care workers (10) . Understanding the clinical symptoms of COVID-19 is important, although the clinical symptoms are indicated nonspecific. Common symptoms include fever, cough and myalgia or fatigue. Patients may initially present with diarrhea and nausea a few days prior to fever, suggesting I n P r e s s fever is dominant but not the premier symptom of infection. A small number of patients can have headache or hemoptysis (26, 32) and even relatively asymptomatic (12) . Affected older men with comorbidities are more likely to have respiratory failure due to severe alveolar damage (31) . Disease onset may show rapid progression to organ dysfunction (e.g., shock, acute respiratory distress syndrome [ARDS], acute cardiac injury, and acute kidney injury) and even death in severe cases (1, 32) . Meanwhile, patients might show normal or lower white blood cell counts, lymphopenia, or thrombocytopenia, with extended activated thromboplastin time and increased C-reactive protein level (1, 26, (31) (32) . In short, a patient having fever and upper respiratory tract symptoms with lymphopenia or leukopenia should be suspected, especially for patients with Wuhan exposure or close contact history. The first task for the clinical diagnostic workflow is to confirm Wuhan exposure history or close contact with people from Wuhan or confirmed patients during the past two weeks. However, the number of the patients with unknown exposure history is increasing due to the rapid and wide spread of the disease. The National Health Commission of China (33, 34) has deleted the term of clinical diagnosis (34) . The final etiology diagnosis of COVID-19 is necessary, which can be further confirmed by positive real-time RT-PCR assay for COVID-19 using respiratory or blood samples or by viral gene sequencing of respiratory or blood samples that are highly homologous with COVID-19. According to the clinical manifestations, confirmed patients are divided into mild, moderate, severe, and critical types ( Table 2) (13, 34, 39) . I n P r e s s consolidation (Figure 3 ) can be seen in severe patients, partially fused into massive consolidation with small pleural effusions and even presenting with "white lung" (11) . Thin slice chest CT functions more effectively in early detection of COVID-19 pneumonia (12, 16) . The largest sample study to date showed that among 3665 confirmed cases, 95.5% (n=3498) patients were diagnosed as pneumonia (25) . Pan et al (40) reviewed 21 confirmed patients who underwent repeated CT at approximately 4 day intervals and found that negative findings were revealed in four patients on early stage (0-4 days after onset of the initial symptom), but repeat chest CT showed lung abnormalities in all of these 4 patients. To date, only five case series studies (16, (40) (41) (42) (43) and some case reports (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) GGO is a hazy increase in attenuation that appears in a variety of interstitial and alveolar processes with preservation of the bronchial and vascular margins (57), while consolidation is an area of opacification obscuring the margins of vessels and airway walls (58) . In patients with COVID-19 pneumonia, focal or multifocal pure GGO (Figures 4a, 5, 6b) and GGO with reticular and/or interlobular septal thickening as typical crazy-paving pattern (Figure 6a ) were often observed, while pure consolidation (Figure 7 ) was relatively less common or absent (16, (40) (41) (42) . Pure GGO lesions (Figure 4a, 5, 9b) can be the early appearance of COVID-19 pneumonia. Chung et al. (41) found one patient with an initial normal chest CT that evolved into a new solitary, rounded peripheral GGO after three days. The reversed CT halo sign defined as a rounded area of ground glass surrounded by a complete or almost complete ring of consolidation can also be observed (16, 49) . Pleural effusion, lung cavitation, lymphadenopathy and calcification are rarely reported (40) (41) (42) (43) (44) (49) (50) . Table 3 summarizes the characteristic chest CT imaging features of COVID-19 pneumonia. Other diseases mimic COVID-19 pneumonia and should be differentiated, including community-acquired pneumonia such as streptococcus pneumonia, mycoplasma and chlamydia related pneumonia, and other coronavirus infections. Differential diagnosis is very important to early quarantine suspected patients with fever and reduce cross infection. Table 4 shows typical clinical and imaging findings of COVID-19 mimics such as common cold, influenza, and other coronaviruses diseases including SARS and MERS (11, (59) (60) (61) (62) (63) . Wuhan exposure history or close contact with confirmed or suspected patients is an essential clue for the diagnosis. However, for patients with unknown epidemiological history, typical clinical and imaging appearance can indicate suspected COVID-19; RT-PCR test should be performed in I n P r e s s these patients. In summary, the diagnosis of COVID-19 should combine epidemiological history, clinical and imaging manifestations, and RT-PCR test (the reference standard). Although chest CT findings are nonspecific for COVID-19 detection, CT findings have been recommended as major evidence of clinical diagnosis in Hubei province by the National Health and Health Commission of China (13) . RT-PCR positive for COVID-19 remains the reference standard (11), but RT-PCR results can be affected by sampling errors and low virus load (64) (65) (66) . Previous SARS studies (67) (68) (69) showed that RT-PCR lacked sensitivity during the first five days of the disease. Current reports show that chest CT may demonstrate pneumonia but multiple RT-PCR tests of nasopharyngeal or throat swabs test negative (12, 53, (70) (71) , and CT can also assess the disease severity of COVID-19 to guide clinical management. Clinical observations showed (1) that intensive care unit (ICU) patients on admission often presented with bilateral multiple lobular and subsegmental consolidation, while non-ICU patients presented with bilateral GGOs and subsegmental consolidation. In severe patients, CT can demonstrate diffuse heterogeneous consolidation with GGOs in bilateral lungs with air bronchial sign and bronchiectasis (Figure 9) , presenting as "white lung" when most lung lobes are affected (15) . Patients also may present with thickening of interlobar septa and bilateral pleura with a small pleural effusion (11, 56) . Additionally, CT surveils disease time course of COVID-19. Chung et al. (41) found that 7 of 8 patients showed marked progression presenting as increasing number, extent, and density of GGOs (Figures 4, 9) . Pan et al (40) reviewed 21 confirmed and recovered patients who underwent repeated CT at approximately 4-day intervals and summarized four stages of the disease: early, progressive, peak, and absorption. They found that GGOs will rapidly grow, demonstrating consolidation and crazy-paving pattern as the disease progresses. The lesions will absorb without crazy-paving pattern on absorption stage, suggesting crazy-paving pattern I n P r e s s as another index to evaluate the disease course. The study by Song et al (42) concluded that greater consolidation indicated disease progression. Some case reports showed that smaller size, extent, and absorption of these lesions indicate the improvement (32, 42, (51) (52) (53) . In conclusion, characteristic chest CT imaging features and Wuhan exposure or close contact Tables Table 1: Note.-Plus signs indicate the relative frequency of the findings from the lowest (+) to the highest (+++). Clinical features of patients infected with 2019 novel coronavirus in Wuhan A novel coronavirus from patients with pneumonia in China Early transmission dynamics in Wuhan, China, of novel coronavirus-Infected pneumonia Importation and human-to-human transmission of a novel coronavirus in vietnam. NEJM First case of 2019 novel coronavirus in the United States The first two cases of 2019-nCoV in Italy: where they come from A new coronavirus associated with human respiratory disease in China the-second-meeting-of-the-international-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 COVID-19): situation report-30 Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Office of state administration of traditional Chinese medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist Imaging changes in patients with 2019-nCov Imaging profile of the COVID-19 infection: Radiologic findings and literature review Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan Strain -National Pathogen Resource Center Pre-fusion structure of a human coronavirus spike protein Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci Severe acute respiratory syndrome-related coronavirus: the species and its viruses -a statement of the coronavirus study group. bioRxiv preprint first posted online Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China Origin and evolution of the 2019 novel coronavirus Wu Han health committee. Notice on the issuance of unexplained viral pneumonia Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv preprint first posted online Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint first posted online Feb A pneumonia outbreak associated with a new coronavirus of probable bat origin Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet Transmission of 2019-nCoV infection from an asymptomatic contact in Germany Novel coronavirus(2019-nCoV): situation report-12 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected Office of State Administration of Traditional Chinese Medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia Middle East respiratory syndrome case definition for reporting to WHO Evidence for camel-to-human transmission of MERS coronavirus COVID-19): situation report-28 World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts (ncov)-infection-presenting-with-mild-symptoms-and-management-ofcontacts Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia CT imaging features of 2019 novel coronavirus (2019-nCoV) Emerging coronavirus 2019-nCoV pneumonia Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China Spectrum of chest CT findings in a familial cluster of COVID-19 infection novel coronavirus (2019-nCoV) pneumonia Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia Chest imaging appearance of COVID-19 infection COVID-19 infection presenting with CT halo sign Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China Pre-and posttreatment chest CT findings: 2019 novel coronavirus (2019-nCoV) pneumonia Longitudinal CT findings in COVID-19 pneumonia: Case presenting organizing pneumonia pattern Severe acute respiratory disease in a Huanan seafood market worker: Images of an early casualty Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease? Imaging of pulmonary viral pneumonia Fleischner Society: glossary of terms for thoracic imaging SARS and MERS: recent insights into emerging coronaviruses Severe acute respiratory syndrome: historical, epidemiologic, and clinical features Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like Disease Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Severe acute respiratory syndrome: historical, epidemiologic, and clinical features World Health Organization. Guidance on regulations for the transport of infectious substances Early diagnosis of SARS coronavirus infection by real time RT-PCR Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR